TuHURA Biosciences, Inc. (HURA) vs Seer, Inc. (SEER)

TuHURA Biosciences, Inc. and Seer, Inc. are both Biotechnology companies. TuHURA Biosciences, Inc. and Seer, Inc. are of similar size ($116.6M and $113.0M). TuHURA Biosciences, Inc. has the higher net margin (0.00% vs −478.1%) and the lower return on invested capital (−74.2% vs −60.8%). Across the 14 metrics below, TuHURA Biosciences, Inc. leads on 7 and Seer, Inc. on 7.

Valuation

Metric HURA SEER Biotechnology median
P/E n/m n/m 8.50
P/S n/m 7.88 9.71
P/B 6.25 0.50 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.64 0.64
EV/Sales n/m (2.87) 9.21
Earnings yield (30.34%) (60.10%) (33.15%)
Free cash flow yield (26.29%) (39.27%) (25.50%)

Profitability

Metric HURA SEER Biotechnology median
Gross margin 0.00% 47.70% 65.16%
Operating margin 0.00% (498.19%) 0.00%
Net margin 0.00% (478.05%) 0.00%
Free cash flow margin 0.00% (309.34%) 0.00%
Return on equity (163.84%) (26.45%) (56.36%)
Return on assets (92.31%) (23.47%) (48.04%)
Return on invested capital (74.20%) (60.78%) 0.00%

Growth

Metric HURA SEER Biotechnology median
Revenue growth (TTM) — (12.71%) 6.02%
EPS growth (last fiscal year) 47.93% 7.91% 30.26%
Revenue growth, 5-year CAGR — 90.78% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HURA SEER Biotechnology median
Debt to equity 0.47 0.00 0.00
Current ratio 0.18 14.74 4.72
Net debt to EBITDA 0.12 2.63 0.96

Dividend

Metric HURA SEER Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric HURA SEER Biotechnology median
Market cap 116.62m 112.96m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack